What antidepressant medications can increase libido?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antidepressant That Increases Libido

Bupropion is the antidepressant of choice when sexual function is a concern, as it is the only antidepressant that consistently improves libido rather than impairing it. 1, 2

Why Bupropion is Unique

Bupropion stands apart from other antidepressants due to its dopamine-norepinephrine reuptake inhibition mechanism, which contrasts sharply with SSRIs and SNRIs that commonly cause sexual dysfunction. 3

Key evidence supporting bupropion's pro-sexual effects:

  • 77% of bupropion-treated patients reported at least one aspect of heightened sexual functioning beyond their pre-illness baseline 4
  • 86% of bupropion patients experienced no adverse sexual effects, compared to only 27% of SSRI-treated patients 4
  • Patients specifically reported significant increases in libido, arousal intensity, orgasm intensity, and orgasm duration 4
  • The FDA drug label explicitly lists "increased libido" as a documented nervous system effect of bupropion 2

Clinical Evidence Across Populations

In breast cancer survivors (a population with particularly high rates of sexual dysfunction from both disease and treatment):

  • Bupropion 150 mg daily significantly improved sexual function scores after 4 weeks of treatment 5
  • The improvement persisted through 8 weeks of treatment 5
  • This is particularly relevant since guidelines note that SSRIs/SNRIs should be stopped in breast cancer patients with sexual dysfunction, as these medications reduce libido and cause anorgasmia 6

In patients switching from SSRIs:

  • 94% of patients who developed orgasm dysfunction on fluoxetine had complete or partial resolution after switching to bupropion 7
  • 81% reported "much" or "very much" increased libido after the switch 7
  • Depression control was maintained or improved during the transition 7

Comparison with Other Antidepressants

SSRIs (fluoxetine, paroxetine, sertraline, citalopram) cause significant sexual dysfunction:

  • Fluoxetine has sexual dysfunction rates of 57.7-62.9% 8
  • These medications significantly decrease libido, arousal, orgasm duration, and orgasm intensity below pre-illness levels 4
  • Paroxetine has particularly high rates of sexual dysfunction compared to other SSRIs 1

SNRIs (venlafaxine, desvenlafaxine, duloxetine) also impair sexual function and should be avoided when libido is a concern 6

Practical Prescribing

Dosing:

  • Start bupropion at 150 mg daily 5
  • Can increase to 300-450 mg daily as needed for depression control 3
  • Sexual function improvements may be evident within 4 weeks 5

Important safety considerations:

  • Bupropion carries a slightly increased seizure risk compared to SSRIs, particularly at doses above 450 mg daily 1, 2
  • Avoid in patients with seizure disorders, eating disorders, or abrupt alcohol/benzodiazepine discontinuation 2
  • Use caution when combining with other medications that lower seizure threshold 2

When bupropion may not be ideal:

  • Patients with comorbid anxiety disorders may respond better to SSRIs despite sexual side effects, as bupropion has less established efficacy for anxiety 1
  • In such cases, consider adding buspirone (off-label) to an SSRI to mitigate sexual dysfunction rather than switching 1

Historical Context

Older studies from the 1980s-1990s established that bupropion has "very low propensity for inducing adverse sexual side effects" and that patients with pre-existing SSRI-induced sexual dysfunction experienced resolution when transferred to bupropion 9, 7. This evidence has remained consistent and is now reflected in current guidelines 1 and FDA labeling 2.

References

Guideline

SSRIs and Sexual Dysfunction in Men: Medication Selection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

An open-label, fixed-dose study of bupropion effect on sexual function scores in women treated for breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology, 2006

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Disfunción Sexual Asociada a Antidepresivos

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Bupropion--an antidepressant without sexual pathophysiological action.

Journal of clinical psychopharmacology, 1985

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.